STOCK TITAN

ScentAI Inc., an Ainos (AIMD) unit, files 13D on 1.16M non-voting shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

ScentAI Inc., a wholly owned subsidiary of Ainos, Inc., filed a Schedule 13D reporting beneficial ownership of 1,160,000 shares of Ainos common stock, representing 16.50% of the outstanding class. These shares have no voting power for so long as they are held by the wholly owned subsidiary.

ScentAI acquired the 1,160,000 Ainos shares on December 30, 2025 in exchange for 116,000,000 shares of ScentAI common stock. The filing states the stake was acquired for investment and general corporate purposes and notes that ScentAI currently has no specific plans for corporate actions involving Ainos, though it may review and change its intentions over time.

Positive

  • None.

Negative

  • None.





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
The numbers in Rows 7, 8, 9, and 11 represents beneficial ownership of 1,160,000 shares of common stock, $0.01 par value (the "Common Stock"), of Ainos, Inc., a Texas corporation (the "Issuer"). All of the shares owned by the Reporting Person have no voting power. For further details, please see Item 3 and Item 6. The percentage in Row 13 is based on the sum of (i) 4,812,634 shares of Common Stock outstanding as of November 13, 2025 as set forth in the Quarterly Report on Form 10-Q of the Issuer filed with the SEC on November 13, 2025, (ii) 950,000 shares of Common Stock granted and vested on November 25, 2025 as special stock awards, which were approved by the shareholders of Ainos, Inc. on November 7, 2025, (iii) 19,531 shares issued for service fee; (iv) 87,816 shares issued from December 5, 2025 to January 26, 2026 in the Issuer's at-the-market offering, and (v) 1,160,000 shares of Common Stock issued to the Reporting Person on December 30, 2025.


SCHEDULE 13D


ScentAI Inc.
Signature:/s/ Chun-Hsien Tsai
Name/Title:Chun-Hsien Tsai, Chief Executive Officer and Director
Date:01/27/2026

FAQ

What ownership stake in Ainos (AIMD) does ScentAI Inc. report?

ScentAI Inc. reports beneficial ownership of 1,160,000 shares of Ainos common stock, representing 16.50% of the outstanding class as calculated in the filing.

Do the 1,160,000 Ainos (AIMD) shares held by ScentAI Inc. have voting rights?

The 1,160,000 shares of Ainos common stock issued to ScentAI Inc. have no voting power for so long as they are owned by a wholly owned subsidiary of Ainos.

How did ScentAI Inc. acquire its 1,160,000 Ainos (AIMD) shares?

ScentAI Inc. acquired 1,160,000 Ainos shares in exchange for 116,000,000 shares of ScentAI common stock issued by ScentAI to Ainos.

What is the relationship between ScentAI Inc. and Ainos (AIMD)?

ScentAI Inc. is described as a wholly owned subsidiary of Ainos, Inc. Ainos is also identified as the parent company of ScentAI in the filing.

What is ScentAI Inc.’s stated purpose for holding Ainos (AIMD) shares?

The filing states ScentAI acquired the Ainos common stock for investment and general corporate purposes, with no specific current plans for actions listed under Item 4.

Who controls ScentAI Inc. and what is their role at Ainos (AIMD)?

Chun-Hsien Tsai is the Chief Executive Officer and sole director of ScentAI Inc. and is also the Chief Executive Officer and a director of Ainos, Inc.

Does ScentAI Inc. report any recent trading activity in Ainos (AIMD) stock?

The filing states that ScentAI Inc. has not effected any transactions in Ainos common stock during the past 60 days, other than the described share exchange.
Ainos Inc

NASDAQ:AIMD

AIMD Rankings

AIMD Latest News

AIMD Latest SEC Filings

AIMD Stock Data

12.06M
3.83M
56.73%
0.13%
2.59%
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN DIEGO